2024-11-07 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Overview**

UnitedHealth Group Inc. (UNH) is a leading health care and insurance company, offering a wide range of health insurance products and services.

The stock has significantly outperformed the S&P 500 (VOO) over the period analyzed. The cumulative return for UNH is 306.16%, while the S&P 500 has returned 139.88%. This results in a difference of 166.28%, which is within the 67.44th percentile of the historical range of outperformance. 

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|------|
| 2015-2017 | 118.8% | 12.4% | 88.6% | 0.9 |
| 2016-2018 | 113.9% | 18.6% | 89.2% | 0.9 |
| 2017-2019 | 82.1% | 23.3% | 39.0% | 0.9 |
| 2018-2020 | 58.6% | 36.0% | 19.5% | 1.1 |
| 2019-2021 | 106.2% | 36.0% | 16.4% | 1.0 |
| 2020-2022 | 81.3% | 36.0% | 63.5% | 0.9 |
| 2021-2023 | 50.6% | 18.3% | 21.8% | 0.5 |
| 2022-2024 | 18.8% | 20.0% | -4.9% | 0.5 |

The analysis shows that UNH consistently outperformed the market with a high alpha, suggesting it generated significant returns beyond what would be expected from the S&P 500. The beta consistently hovering around 1 indicates that the stock's price movement is generally in line with the market.

**2. Recent Price Movement**

| Indicator | Value |
|---|---|
| Closing Price | 596.69 |
| 5-Day Moving Average | 570.71 |
| 20-Day Moving Average | 571.98 |
| 60-Day Moving Average | 581.08 |

The stock is currently trading above its 5, 20, and 60-day moving averages, suggesting a bullish trend. However, the recent price action might be influenced by short-term volatility. 

**3. Technical Indicators**

| Indicator | Value | Interpretation |
|---|---|---|
| RSI | 69.71 | The RSI is in the overbought territory, indicating potential short-term correction. |
| PPO | 0.35 |  The PPO suggests a positive momentum and potential for further price appreciation. |
| Delta_Previous_Relative_Divergence | -1.1 |  This indicates a short-term downtrend in relative price strength compared to the previous period. |
| Expected_Return | 53.27% |  This represents the expected long-term (2+ years) outperformance compared to the S&P 500, assuming a continued positive outlook. |

**4. Recent Earnings and Outlook**

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2024-11-04 | 6.31 | 92.36 B$ |

The company's most recent earnings report (2024-11-04) showed a strong EPS of 6.56, exceeding analyst expectations. The revenue also grew significantly, indicating a positive trend.

**5. Financial Information**

**1) Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30 | $99.18B | 21.56% |
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |

The data demonstrates consistent revenue growth and robust profitability, with a stable profit margin. This highlights the company's strong financial performance and ability to generate sustainable profits.

**2) Capital and Profitability**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $94.53B | 6.41% |
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |

The data shows a healthy level of equity and a generally positive ROE, though there is fluctuation. This indicates that UNH has strong capital reserves and is using its resources effectively to generate profits.

**6. News and Recent Events**

* **Recent Earnings Release:** UNH recently released its Q3 2024 earnings report, exceeding analyst expectations for both EPS and revenue. The positive results fueled a surge in the stock price.
* **Industry Outlook:** The healthcare sector is projected to continue growing, driven by factors like an aging population and increasing healthcare costs. UNH's strong market position and diversified business model make it well-positioned to benefit from these trends.
* **Analyst Opinions:** Most analysts maintain a positive outlook for UNH, citing its robust financial performance, strong market share, and growth prospects.

**7. Overall Analysis**

UNH's stock performance has consistently exceeded the market, driven by strong financial performance and a positive industry outlook. The company's recent earnings report further reinforces its growth trajectory. While short-term volatility is expected, the long-term growth potential remains attractive, making UNH a solid investment option for investors seeking exposure to the healthcare sector.

**Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice. It is crucial to conduct your own due diligence and consult with a qualified financial advisor before making any investment decisions. 
